Jatenzo Cost in South Carolina (2026): Cash Price, Insurance, and Savings Options

What Does Jatenzo Actually Cost in South Carolina?

The sticker price for brand-name Jatenzo at South Carolina retail pharmacies sits near $900 per month in 2026, matching the Tolmar Pharmaceuticals list price. That number applies to patients paying entirely out of pocket, without insurance or discount programs. Jatenzo was the first oral testosterone undecanoate approved by the FDA in March 2019 for adult males with conditions associated with a deficiency or absence of endogenous testosterone (FDA approval label).

The actual amount you pay depends on three variables: your insurance formulary status, your pharmacy's acquisition cost, and whether you qualify for manufacturer or third-party savings programs. At full price, a 30-day supply of the standard starting dose (237 mg twice daily) will run close to that $900 figure at most SC pharmacies, including CVS, Walgreens, and independent locations.

Price variation between pharmacies in South Carolina tends to be narrow because the drug has a single manufacturer. Unlike injectable testosterone cypionate, which has multiple generic manufacturers and can cost as little as $30 to $50 per month, Jatenzo has no generic equivalent as of May 2026. Testosterone undecanoate oral capsules remain patent-protected, keeping the cash price elevated.

For context, the Swerdloff et al. key trial (N=166) that supported Jatenzo's approval demonstrated that 87% of participants achieved testosterone levels within the normal eugonadal range (300 to 1 to 100 ng/dL) at the 237 mg twice-daily dose (Swerdloff et al., J Clin Endocrinol Metab 2020). The drug works. The question is whether South Carolina patients can afford it.

Does South Carolina Medicaid Cover Jatenzo?

No. South Carolina Medicaid does not cover Jatenzo as of 2026. The state's preferred drug list excludes brand-name oral testosterone undecanoate. Medicaid beneficiaries in SC who need testosterone replacement therapy are typically directed toward injectable testosterone cypionate or topical formulations such as AndroGel, both of which carry lower acquisition costs for the state program.

This exclusion is not unusual. Most state Medicaid programs nationwide have declined to add Jatenzo to their formularies due to its cost relative to older testosterone delivery methods. The South Carolina Department of Health and Human Services manages the state's Medicaid preferred drug list, and prior authorization requests for non-preferred testosterone products are reviewed on a case-by-case basis. In practice, approval for Jatenzo through SC Medicaid prior authorization is rare.

Patients on Medicaid who specifically need an oral testosterone formulation (for instance, those with needle phobia severe enough to interfere with treatment adherence, or those with skin conditions that prevent topical use) should have their prescriber document these clinical reasons in a prior authorization request. The Endocrine Society's 2018 clinical practice guideline for testosterone therapy in men with hypogonadism supports individualized route-of-administration decisions based on patient preference and clinical factors (Bhasin et al., J Clin Endocrinol Metab 2018).

Which Commercial Insurance Plans Cover Jatenzo in SC?

Coverage for Jatenzo among commercial insurers in South Carolina is inconsistent. Some Blue Cross Blue Shield of South Carolina plans include Jatenzo on a specialty tier (Tier 4 or Tier 5) with prior authorization required. Other SC-market insurers, including certain Cigna and Aetna plans, either exclude it outright or place it on a non-preferred brand tier with a copay that can exceed $150 to $300 per month even after insurance.

To determine whether your specific plan covers Jatenzo, call the number on the back of your insurance card and ask three questions: Is oral testosterone undecanoate (Jatenzo) on my formulary? What tier is it? Does it require prior authorization or step therapy? Step therapy requirements, which are common, may require you to try and fail on a cheaper testosterone product (such as injectable testosterone cypionate) before the insurer will approve Jatenzo.

The American Urological Association has noted that route of testosterone delivery should be a shared decision between clinician and patient, accounting for pharmacokinetics, side-effect profile, and patient preference (Mulhall et al., J Urol 2018). If your insurer denies coverage, your prescriber can file a formulary exception request citing clinical necessity.

Federal employee plans (FEHB) and TRICARE have their own formulary processes. TRICARE covers testosterone replacement therapy but restricts brand-name products when generics or lower-cost alternatives exist. Active-duty military and veterans in South Carolina with documented hypogonadism should check with their TRICARE pharmacy benefits manager or the VA formulary for the most current status.

How the Tolmar Savings Card Works in South Carolina

Tolmar Pharmaceuticals offers a manufacturer copay savings card for Jatenzo that can reduce out-of-pocket costs for commercially insured patients. Eligible patients with commercial insurance may pay as little as $0 per month, depending on their plan's cost-sharing structure. The savings card covers the gap between the patient's copay obligation and a preset manufacturer subsidy amount.

Key eligibility rules for the Tolmar savings card:

• You must have commercial (private) insurance. Patients with Medicaid, Medicare, TRICARE, or other government-funded insurance are not eligible.
• The card typically has a maximum annual benefit cap, which Tolmar has set at varying levels. Check the current terms at the Jatenzo website or by calling the number on the savings card.
• The card is accepted at most SC retail pharmacies, including chains and independents that process commercial prescription claims.

Patients without any insurance cannot use the copay savings card. However, Tolmar does offer a separate patient assistance program (PAP) for uninsured or underinsured patients who meet income requirements. The PAP application typically requires documentation of household income below a specified threshold, often 400% of the federal poverty level.

A common mistake: patients assume the savings card eliminates the entire cost. It does not. The card offsets your copay or coinsurance. If your insurer does not cover Jatenzo at all, the savings card will not apply because there is no insurance claim to attach it to. In that scenario, you would need to pursue the PAP or consider alternatives.

Compounded Oral Testosterone Undecanoate in South Carolina

Compounded oral testosterone undecanoate is available in South Carolina through licensed 503A compounding pharmacies. Under federal law (the Drug Quality and Security Act of 2013), 503A pharmacies can compound medications pursuant to valid individual prescriptions when a prescriber determines that a compounded preparation is medically appropriate for a specific patient (FDA, DQSA Section 503A).

The cost difference is dramatic. Compounded oral testosterone undecanoate from a 503A pharmacy can cost a fraction of the $900 brand-name price. Some SC compounding pharmacies offer 30-day supplies for under $100, though prices vary by pharmacy and dosage.

Important considerations before choosing compounded oral TU:

South Carolina permits 503A compounding, and state pharmacy law does not explicitly prohibit compounding of testosterone undecanoate capsules. However, compounded products are not FDA-approved and are not subject to the same bioequivalence testing as Jatenzo. The Swerdloff et al. study that demonstrated Jatenzo's efficacy used the specific Jatenzo formulation with its proprietary Self-Emulsifying Drug Delivery System (SEDDS), which enhances oral bioavailability via lymphatic absorption (Swerdloff et al., 2020). A compounded capsule may not replicate these absorption characteristics.

The Endocrine Society has not issued a position statement specifically on compounded testosterone undecanoate, but the organization has previously expressed concerns about the variability of compounded hormone preparations. Dr. Bradley Anawalt, an endocrinologist at the University of Washington and past Endocrine Society president, stated: "Compounded testosterone products have not undergone the rigorous testing for safety, efficacy, and consistency that FDA-approved products have. Patients should be informed of this distinction" (Endocrine Society Clinical Statement).

If you choose a compounded product, verify that the pharmacy holds a valid South Carolina Board of Pharmacy 503A license and follows USP 795/800 compounding standards. Ask the pharmacy whether they perform potency testing on their testosterone undecanoate capsules.

Getting Jatenzo via Telehealth in South Carolina

South Carolina permits telehealth prescribing of Jatenzo. State law allows prescribers to establish a patient-provider relationship via synchronous audio-video consultation, which satisfies the requirements for prescribing Schedule III controlled substances like testosterone undecanoate.

The Ryan Haight Online Pharmacy Consumer Protection Act (federal law) requires that a valid prescription for a controlled substance dispensed via the internet must be issued by a practitioner who has conducted at least one in-person medical evaluation of the patient, unless an exception applies. The DEA's pandemic-era telehealth flexibilities, which temporarily waived the in-person requirement for initial controlled substance prescriptions, have been subject to ongoing regulatory updates. As of early 2026, the DEA has proposed rules that would allow certain registered telehealth practitioners to prescribe Schedule III through V controlled substances via telehealth without a prior in-person visit, subject to specific safeguards (DEA Proposed Rule, 2024).

For South Carolina patients, the practical pathway looks like this: a licensed prescriber (MD, DO, NP, or PA with prescriptive authority in SC) evaluates you via telehealth, orders confirmatory lab work (total testosterone, measured on two separate mornings, with results below 300 ng/dL per the Endocrine Society guideline), and writes the Jatenzo prescription if clinically indicated. The prescription is sent to a pharmacy of your choice in SC.

Telehealth TRT clinics that operate in South Carolina must hold appropriate SC medical licenses. The South Carolina Board of Medical Examiners requires that telehealth practitioners be licensed in the state where the patient is located at the time of the visit.

Jatenzo vs. Other Testosterone Options: A Cost Comparison for SC Patients

Understanding where Jatenzo fits among testosterone replacement options helps South Carolina patients make informed decisions about cost and convenience. The following comparison uses approximate 2026 SC retail cash prices.

Injectable testosterone cypionate (200 mg/mL, 10 mL vial) costs $30 to $80 per month at SC pharmacies and is the most affordable option. It requires intramuscular or subcutaneous injection, typically every 1 to 2 weeks. Nearly all insurance plans and SC Medicaid cover it.

Topical testosterone gel (AndroGel 1.62%, 30-day supply) runs $500 to $600 per month at cash price, though generics can bring this to $50 to $150. Most insurance plans cover generic topical testosterone. Transfer risk to household contacts is a known limitation documented in FDA labeling.

Testosterone nasal gel (Natesto) costs approximately $500 to $700 per month and requires dosing three times daily. Insurance coverage is limited.

Jatenzo, at $900 per month cash, is the most expensive option. Its advantage is oral dosing with food, twice daily, avoiding injections and transdermal transfer risk. In the Swerdloff trial, the most common adverse events were headache (5.4%), increased hematocrit (5.4%), nausea (3.6%), and increased blood pressure (3.0%) (Swerdloff et al., 2020).

The FDA's approval label for Jatenzo includes a boxed warning about the potential for blood pressure increases, which was not required for injectable or topical testosterone products. The clinical significance of this finding relative to other TRT routes remains a subject of ongoing study. A post-marketing cardiovascular outcomes study was required by the FDA as a condition of approval (FDA Jatenzo Label).

Practical Steps to Lower Your Jatenzo Cost in South Carolina

If Jatenzo is the right clinical choice for you, here is a step-by-step approach to minimizing your cost in SC.

First, confirm your insurance formulary status. Call your insurer and ask specifically about oral testosterone undecanoate. If it requires prior authorization, have your prescriber submit the PA with documentation of your diagnosis (two confirmed morning testosterone levels below 300 ng/dL) and clinical justification for the oral route.

Second, apply for the Tolmar savings card if you have commercial insurance. This can reduce your copay to $0 in many cases.

Third, if you are uninsured, apply for the Tolmar patient assistance program. Income documentation will be required.

Fourth, if cost remains prohibitive, discuss compounded oral testosterone undecanoate with your prescriber. Ensure the compounding pharmacy is 503A-licensed in South Carolina. Request a Certificate of Analysis showing potency verification for the specific batch.

Fifth, consider whether a different testosterone formulation (injectable cypionate, for example) might meet your clinical needs at a fraction of the cost. The Endocrine Society guideline states that the choice of testosterone formulation should be a shared decision based on pharmacokinetics, patient preference, cost, and availability (Bhasin et al., 2018).

Patients who are prescribed Jatenzo should take it with food. Fat content in the meal enhances absorption through the lymphatic system. Taking Jatenzo on an empty stomach significantly reduces bioavailability and may result in subtherapeutic testosterone levels, requiring dose adjustment and repeat lab work.